Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.

Home
/
Records
/
Fda Inspections
/
AbbVie Inc.

FDA Inspection

•AbbVie Inc.•April 2, 2026

FDA Inspection 1302298 - AbbVie Inc. - April 02, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns AbbVie Inc., with an inspection on April 2, 2026, issued by the Chicago District Office, covering human drugs.

Company: AbbVie Inc.
Inspection Date: April 2, 2026
Product Type: Human Drugs
Office: Chicago District Office

Open in Dashboard

ID · 00651199-0676-4364-ac4b-a2e38a34895a

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

info@globalkeysolutions.net

Quick Links

Home Platform Overview Media

KeyPedia™ Lite

Browse Hub Database Directory Records Companies Offices People Careers About Us Founding Team Meet Our Experts Partners

Legal & Ethics

Privacy Policy Terms of Service Our Values & Mission Code of Ethics & AI Policy

©2026, Global Key Solutions All rights reserved.

FDA Inspection 1302298 - AbbVie Inc. - April 02, 2026 | KeyPedia